Hawaii Clinical Research Center

Honolulu, Hawaii 96826

0 studies enrolling now · 10 studies all time

What they study most

Depression, Depressive Disorder, Generalized Anxiety Disorder, Healthy, Major Depressive Disorder, Orthopoxviral Disease, Psychotic Disorders, Schizophrenia

Studies at this site

• Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD) — Stopped early
• Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder — Completed
• Safety and Efficacy of Cariprazine in Patients With Schizophrenia — Completed
• Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder — Completed
• Study to Evaluate the Pharmacokinetics, Tolerability, and Safety of ACT-128800 in Japanese and Caucasian Healthy Male and Female Subjects — Completed
• A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder — Completed
• Major Depressive Disorder With Mixed Features — Withdrawn before enrolling
• A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression — Completed
• Safety, Tolerability, Pharmacokinetics (PK) of the Anti-Orthopox Drug, ST-246 — Completed
• rEEG Guided Pharmacotherapy of Subjects With Depression Treatment Failure — Completed